MedPath

The Physical Activity and Nutrition in Children (PANIC) Study

Not Applicable
Conditions
Overweight
Blood Pressure
Atherosclerosis
Glucose Metabolism Disorders
Lipid Metabolism Disorders
Interventions
Behavioral: lifestyle counseling
Registration Number
NCT01803776
Lead Sponsor
University of Eastern Finland
Brief Summary

The Physical Activity and Nutrition in Children (PANIC) Study is a single-centre controlled trial on the effects of a combined physical activity and dietary intervention on cardiometabolic risk factors and other health outcomes in a population sample of children from the city of Kuopio, Finland. The study provides novel scientific information for the identification of cardiometabolic diseases and other chronic diseases since fetal period and for the prevention of these chronic diseases since childhood.

The main hypothesis of the PANIC study is that individuals at increased risk of cardiometabolic diseases and other chronic diseases can be identified in childhood and that it is possible to start the prevention of these chronic diseases by a long-term physical activity and dietary intervention since childhood.

Detailed Description

We will investigate a population sample of 512 children from the city of Kuopio, Finland. The children will be recruited in 2007-2009 when they are 7-9 years of age and when they will start the first grade in primary schools of the city of Kuopio. The children will be allocated to the combined physical activity and dietary intervention group and the control group after baseline examinations carried out in 2007-2009. The intervention group will undergo individualized and family-based physical activity and dietary intervention, including six intervention visits, for two years. All children from the intervention and control group will be invited to 2-year follow-up examinations carried out in 2009-2011 when they are 9-11 years of age. The intervention group will continue with a less intensive physical activity and dietary intervention until 8-year follow-up examinations carried out in 2015-2017 when the participants are 15-17 years of age. The participants from the intervention and control group will continue with an open follow-up until 14-year follow-up examinations in 2021-2023 when they are 21-23 years of age. All of these study phases will include comprehensive and detailed assessments of behavioral, biological, environmental, and genetic risk factors for cardiometabolic diseases and other chronic diseases. The results of the PANIC Study will help in 1) decreasing the risk of developing cardiometabolic diseases and other chronic diseases since childhood by increasing physical activity, decreasing sedentary time, and improving diet, 2) identifying children and adolescents at increased risk of cardiometabolic diseases and other chronic diseases who would benefit most from the physical activity and dietary interventions, 3) targeting children and adolescents, particularly those at increased risk of cardiometabolic diseases and other chronic diseases, for more careful health examinations, physical activity and dietary interventions, and health follow-up, and 4) preventing cardiometabolic diseases and other chronic diseases as well as their societal consequences in adulthood.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
504
Inclusion Criteria
  • boys and girls, 6-9 years of age at baseline, from the city of Kuopio, Finland
Exclusion Criteria
  • physical disabilities that could hamper participation in the intervention
  • no time or motivation to attend the study

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
lifestyle counselinglifestyle counselingPhysical activity and dietary counseling
Primary Outcome Measures
NameTimeMethod
Change in insulin resistanceFrom baseline to 2-year follow-up (childhood), 8-year follow-up (adolescence), and 14-year follow-up (early adulthood)

Fasting serum insulin

Change in fasting plasma glucoseFrom baseline to 2-year follow-up (childhood), 8-year follow-up (adolescence), and 14-year follow-up (early adulthood)

Fasting plasma glucose

Change in body compositionFrom baseline to 2-year follow-up (childhood), 8-year follow-up (adolescence), and 14-year follow-up (early adulthood)

Body fat percentage and lean body mass assessed by dual-energy X-ray absorptiometry

Secondary Outcome Measures
NameTimeMethod
Change in cognitive functionFrom baseline to 2-year follow-up (childhood), 8-year follow-up (adolescence), and 14-year follow-up (early adulthood)

General mental ability assessed by Raven's Coloured Progressive Matrices

Change in sedentary timeFrom baseline to 2-year follow-up (childhood), 8-year follow-up (adolescence), and 14-year follow-up (early adulthood)

Sedentary time assessed objectively by heart rate and body movement monitoring

Change in lipid metabolismFrom baseline to 2-year follow-up (childhood), 8-year follow-up (adolescence), and 14-year follow-up (early adulthood)

Biomarkers of lipid metabolism (fasting triglycerides, HDL cholesterol and LDL cholesterol)

Change in dietFrom baseline to 2-year follow-up (childhood), 8-year follow-up (adolescence), and 14-year follow-up (early adulthood)

Food consumption and nutrient intake assessed by 4-day dietary recording

Change in physical activityFrom baseline to 2-year follow-up (childhood), 8-year follow-up (adolescence), and 14-year follow-up (early adulthood)

Physical activity assessed objectively by heart rate and body movement monitoring

Change in cardiorespiratory fitnessFrom baseline to 2-year follow-up (childhood), 8-year follow-up (adolescence), and 14-year follow-up (early adulthood)

Maximal workload and peak oxygen consumption assessed by a maximal exercise test on a bicycle ergometer

Change in bone mineral densityFrom baseline to 2-year follow-up (childhood), 8-year follow-up (adolescence), and 14-year follow-up (early adulthood)

Change in bone mineral density assessed by dual-energy X-ray absorptiometry

Change in liver adiposityFrom baseline to 2-year follow-up (childhood), 8-year follow-up (adolescence), and 14-year follow-up (early adulthood)

Biomarkers of liver adiposity (alanine aminotransferase and gamma glutamyltransferase)

Change in blood pressureFrom baseline to 2-year follow-up (childhood), 8-year follow-up (adolescence), and 14-year follow-up (early adulthood)

Systolic and diastolic blood pressure at rest

Change in costs associated with the use of healthcare servicesFrom baseline to 2-year follow-up (childhood), 8-year follow-up (adolescence), and 14-year follow-up (early adulthood)

Costs associated with the use of healthcare services received from national and local health registries

Change in the use of healthcare servicesFrom baseline to 2-year follow-up (childhood), 8-year follow-up (adolescence), and 14-year follow-up (early adulthood)

Use of healthcare services received from national and local health registries

Trial Locations

Locations (1)

University of Eastern Finland

🇫🇮

Kuopio, Finland

© Copyright 2025. All Rights Reserved by MedPath